drugset

drugset / Trial / NCT00808262

Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease

NCT00808262 ↗

Phase 1/2 Completed 21 enrolled Neovacs

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the safety and the immune response induced by active immunization through a TNFa kinoid in patients with Crohn's disease.

Timeline

Start: 2008-10
Primary completion: 2010-12
Completion: 2010-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TNFa Kinoid	Vaccine	—	—

Indications